Skip to main content
Clinical Trials/NCT04374474
NCT04374474
Withdrawn
Phase 4

Olfactory Retraining Therapy and Budesonide Nasal Rinse for Anosmia Treatment in Patients Post-CoVID 19. A Randomized Controlled Trial

Overview

Phase
Phase 4
Intervention
smell household Items
Conditions
Olfactory Disorder
Sponsor
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Locations
1
Primary Endpoint
Change from Baseline Snap and Sniff Threshold Test at 3 months
Status
Withdrawn
Last Updated
9 months ago

Overview

Brief Summary

The study will be a randomized controlled trial, involving patients with hyposmia/anosmia of onset immediately after an upper respiratory viral illness, assigned to three distinct study arms. Nasal irrigations will be prescribed to all three groups (BID). In addition, one arm will receive a paper hand-out about post-viral anosmia with instructions to smell common household items (current care) and act as a control group. The second group will receive an essential oil retraining kit, whereas the third group will receive the same olfactory training kit and a prescription to use budesonide with the nasal irrigations. Olfactory scores will be tested at the enrollment, 3 months and at 6 months.

Registry
clinicaltrials.gov
Start Date
January 10, 2021
End Date
March 10, 2022
Last Updated
9 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Adults 18 years of age or older
  • Hyposmia/anosmia of onset immediately after an upper respiratory viral illness confirmed on Snap n' Sniff threshold testing,
  • Capable, in the opinion of the primary investigator, of providing informed consent to participate in the study. Participants are required to sign an informed consent form indicating they understand the purpose and nature of the study, and that they are willing to participate.

Exclusion Criteria

  • active cigarette smoker
  • chronic rhinosinusitis
  • head trauma with loss of consciousness
  • inability to read/understand English
  • previous hyposmia/anosmia complaint
  • pregnancy
  • previous sinus
  • skull base or brain surgery
  • current participation in another clinical trial at the time of initial visit

Arms & Interventions

Control Group

The participants, randomly assigned to this arm, will receive a paper hand-out about post-viral anosmia with instructions to smell common household items (current care). Besides, it will be prescribed nasal irrigation twice a day.

Intervention: smell household Items

Control Group

The participants, randomly assigned to this arm, will receive a paper hand-out about post-viral anosmia with instructions to smell common household items (current care). Besides, it will be prescribed nasal irrigation twice a day.

Intervention: Nasal Irrigation

Olfactory Retraining Group

The participants, randomly assigned to this arm, will receive instructions on olfactory retraining and will also be given an essential oil retraining kit, which they will use twice a day. Besides, it will be prescribed nasal irrigation twice a day.

Intervention: Olfactory retraining

Olfactory Retraining Group

The participants, randomly assigned to this arm, will receive instructions on olfactory retraining and will also be given an essential oil retraining kit, which they will use twice a day. Besides, it will be prescribed nasal irrigation twice a day.

Intervention: Nasal Irrigation

Olfactory Retraining_Budesonide Group

The participants, randomly assigned to this arm, will receive instructions on olfactory retraining, the olfactory training kit and it will be prescribed nasal irrigation with Budesonise, twice a day.

Intervention: Olfactory retraining

Olfactory Retraining_Budesonide Group

The participants, randomly assigned to this arm, will receive instructions on olfactory retraining, the olfactory training kit and it will be prescribed nasal irrigation with Budesonise, twice a day.

Intervention: corticosteroid nasal irrigation

Outcomes

Primary Outcomes

Change from Baseline Snap and Sniff Threshold Test at 3 months

Time Frame: 3 months

Score from the Snap and Sniff Olfactory Test results

Change from baseline Smell Identification Test (SIT) at 3 months

Time Frame: 3 months

Score from the Smell Identification test results.

Change from baseline Smell Identification Test (SIT) at 6 months

Time Frame: 6 months

Score from the Smell Identification test results.

Change from Baseline Snap and Sniff Threshold Test at 6 months

Time Frame: 6 months

Score from the Snap and Sniff Olfactory Test results

Secondary Outcomes

  • Change from baseline SF-36 health survey at 6 months(6 months)
  • Change from baseline QOD-NS at 3 months(3 months)
  • Adherence to the Study Protocol(6 months)
  • Recovery(6 months)
  • Change from baseline SF-36 health survey at 3 months(3 months)
  • Change from baseline QOD-NS at 6 months(6 months)

Study Sites (1)

Loading locations...

Similar Trials